Evidence map›Paper›PMID 9843987›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1998

Identification of a proline-binding motif regulating CD2-triggered T lymphocyte activation.

K Nishizawa, C Freund, J Li, G Wagner, E L Reinherz

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 111 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. CD2 Immunobiology.Frontiers in immunology · 2020
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

K NishizawaLaboratory of Immunobiology, Dana-Farber Cancer Institute, and Department of Medicine, Harvard Medical School, Boston, MA 02115, USA.
C Freund
J Li
G Wagner
E L Reinherz
Dana-Farber Cancer Institute · USHarvard University · US

Funding

GENES ENCODING THE T CELL ANTIGEN RECEPTORR01AI021226 · NIAID · DANA-FARBER CANCER INSTITUTE · PI REINHERZ, ELLIS L · 1985 to 2006
$3.8M
FEASIBILITY STUDY TO PRODUCE HETEROGENOUS IMMUNOGLOBULINR43AI027581 · NIAID · HASTINGS LABS · PI HASTINGS, DONALD H · 1989 to 1989
–
NIAID NIH HHS AI21226NIAID NIH HHS AI27581NIAID NIH HHS R01 AI021226
6 · The paper itself

Abstract

An intracellular protein termed CD2 binding protein 2 (CD2BP2), which binds to a site containing two PPPGHR segments within the cytoplasmic region of CD2, was identified. Mutagenesis and NMR analysis demonstrated that the CD2 binding region of CD2BP2 includes a 17-aa motif (GPY[orF]xxxxM[orV]xxWxxx GYF), also found in several yeast and Caenorhabditis elegans proteins of unknown function. In Jurkat T cells, over-expression of the isolated CD2BP2 domain binding to CD2 enhances the production of interleukin 2 on crosslinking of CD2 but not the T cell receptor. Hence, a proline-binding module distinct from SH3 and WW domains regulates protein-protein interactions.

Indexed as

Lymphocyte ActivationAdaptor Proteins, Signal TransducingAmino Acid SequenceAnimalsBase SequenceBinding SitesCaenorhabditis elegansCarrier ProteinsCD2 AntigensDNA Mutational AnalysisHumansMolecular Sequence DataProlineSaccharomyces cerevisiaeSequence AnalysisT-LymphocytesAdaptor Proteins, Signal TransducingCarrier ProteinsCD2 AntigensCD2BP2 protein, humanProline

Identifiers

PMID9843987
PMCPMC24547
OpenAlexW1966951979

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.